laoshan老山品牌怎么样 申请店铺

我要投票 laoshan老山在蜂王浆行业中的票数:118 更新时间:2025-03-09
laoshan老山是哪个国家的品牌?「laoshan老山」是 南京老山药业股份有限公司 旗下著名品牌。该品牌发源于江苏,由创始人曹卫华在1998-12-22期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力laoshan老山品牌出海!通过在本页面挂载laoshan老山品牌的产品链接和联系邮箱,可以提高laoshan老山产品曝光!跨境电商爆单神器,目前只要100元/年哦~

laoshan老山怎么样

南京老山药业股份有限公司前身是南京老山制药厂,1971年3月由南京老山林场和在老山的江苏“五·七”干校干部、科技人员及知识青年共同创建。1998年12月,制药厂改制为有限公司。2001年12月,公司整体改制为股份有限公司。2007年市委市政府将南京老山林场划转浦口区管理。2012年5月,江苏省南京浦口经济开发总公司回购公司民营法人股份,公司成为开发区下属国有股份公司。

公司位于江苏省南京浦口经济开发区,是专业从事蜂产品、真菌和抗生素药品研制、生产、加工与销售的现代生物制药企业,现已发展成为“江苏省重点高新技术企业”和“农业产业化国家重点龙头企业”。

公司国有控股95%,旗下6家子公司,销售覆盖国内主要市场,并跟十多个国家和地区数十家外商客户建立起长期外贸和友好往来关系。公司老山“胃乐宁片”被列入“中药保护品种”目录,独家生产;老山“蜂王浆冻干粉”被认定为“中国名牌农产品”,占全国60%以上市场份额;公司主要产品通过了“绿色食品”、“有机产品”、江苏“名牌产品”和“高新技术产品”认证;“老山”商标被认定为“驰名保护”和江苏省“著名商标”,“老山”品牌荣获中国蜂产品“优秀品牌”、江苏蜂产品“首选品牌”和江苏25大“功勋品牌”等荣誉称号。

随着老山药业的不断壮大,老山野生资源,尤其是蜜蜂资源已不能满足企业蓬勃发展的需要。为了扩大优质原料来源,企业开始走出老山、走向全国,在江苏、新疆、云南、内蒙等地的优质生态区域建立起20多个绿色和有机基地。老山药业将养蜂基地作为“第一车间”,对基地5公里范围内的蜜源植物、水源进行统一规划、改造和动态监测,使其远离城区、工矿区、交通主干线、工业污染源、生活垃圾场等。同时公司还牵头成立了“老山蜂业合作联社”,加强对蜂农的组织联系、技术培训和利益联结,建立起“溯源管理”体系,要求标识统一、管理统一、饲料统一、蜂药统一、记录统一、收购统一,开展人性化养蜂,科学化、标准化生产。老山养蜂基地曾两次作为中国蜂业的唯一代表顺利通过欧盟残留监控检查,被欧盟专家评价为“象教学基地一样的蜂场”,成为推动欧盟解禁、恢复出口的“有功单位”,其中新疆伊犁基地被国家认定为“有机基地”,公司还被认定为“全国蜂产品安全与标准化生产基地”、江苏省农产品“出口示范基地”。

公司已取得4项发明专利、12项实用新型专利,并成功拟定5个蜂业“国家标准”,正在拟定一项“国际标准”。公司率先通过了GMP、ISO9001、ISO22000、ISO14000等体系认证,两次荣获“江苏省质量奖”。公司原料基地通过了“有机基地”和“江苏省农产品出口示范基地”认定,曾两次作为中国蜂业的唯一代表通过了欧盟检查。老山药业以“绿色?和谐?共成长”为核心价值观,在巩固国内蜂业龙头地位的同时,正在努力成为全球蜂业的领跑者。

Nanjing Laoshan Pharmaceutical Co., Ltd., formerly known as Nanjing Laoshan pharmaceutical factory, was jointly founded in March 1971 by Nanjing Laoshan Forest Farm and Jiangsu "May 7th" cadre school cadres, scientific and technological personnel and knowledge youth in Laoshan. In December 1998, the pharmaceutical factory was transformed into a limited company. In December 2001, the company was restructured into a joint stock limited company. In 2007, the municipal Party committee and the municipal government transferred Nanjing Laoshan Forest Farm to Pukou District for management. In May 2012, Jiangsu Nanjing Pukou Economic Development Corporation repurchased the private legal person shares of the company, and the company became a state-owned joint-stock company under the development zone. Located in Pukou Economic Development Zone, Nanjing, Jiangsu Province, the company is a modern biopharmaceutical enterprise specializing in the development, production, processing and sales of bee products, fungi and antibiotic drugs. It has developed into "key high-tech enterprise of Jiangsu Province" and "national key leading enterprise of agricultural industrialization". The company has a state-owned holding of 95%, 6 subsidiaries, sales coverage of major domestic markets, and has established long-term foreign trade and friendly relations with dozens of foreign customers in more than 10 countries and regions. The company's Laoshan "weilening tablet" is listed in the catalogue of "protected varieties of traditional Chinese medicine" for exclusive production; Laoshan "royal jelly freeze-dried powder" is recognized as "China's famous agricultural products", accounting for more than 60% of the market share of the country; the company's main products have passed the certification of "green food", "organic products", Jiangsu "famous products" and "high-tech products"; the "Laoshan" trademark has been recognized For "well-known protection" and "famous trademark" of Jiangsu Province, "Laoshan" brand won the honorary titles of "excellent brand" of Chinese bee products, "preferred brand" of Jiangsu bee products and "meritorious brand" of Jiangsu 25. With the growing of Laoshan pharmaceutical industry, the wild resources, especially the bee resources, can not meet the needs of the vigorous development of enterprises. In order to expand the source of high-quality raw materials, enterprises began to go out of the old mountains and go to the whole country, and set up more than 20 green and organic bases in high-quality ecological areas in Jiangsu, Xinjiang, Yunnan, Inner Mongolia and other places. Laoshan pharmaceutical takes beekeeping base as the "first workshop", and makes unified planning, transformation and dynamic monitoring of honey plants and water sources within 5km of the base, so as to make it far away from the urban area, industrial and mining areas, traffic trunk lines, industrial pollution sources, domestic waste yards, etc. At the same time, the company also led the establishment of "Laoshan Bee Industry Cooperation Association", strengthened the organizational contact, technical training and interest connection for bee farmers, established a "traceability management" system, which requires unified identification, management, feed, bee medicine, record and purchase, carried out humanized bee keeping, scientific and standardized production. Laoshan beekeeping base, as the only representative of China's beekeeping industry, has successfully passed the EU residue monitoring and inspection twice. It has been appraised as "a beehive like a teaching base" by EU experts, and has become a "meritorious unit" to promote the lifting of EU ban and the resumption of export. Among them, Yili base in Xinjiang has been recognized as "organic base" by the state, and the company has also been recognized as "national bee product safety and standardized production" Production base ", Jiangsu agricultural products" export demonstration base ". The company has obtained 4 invention patents and 12 utility model patents, and has successfully formulated 5 "national standards" for bee industry, and is preparing an "international standard". The company took the lead in passing GMP, ISO9001, ISO22000, ISO14000 and other system certification, and twice won the "Jiangsu Quality Award". The raw material base of the company has passed the "organic base" and "Jiangsu agricultural products export demonstration base", and has twice passed the EU inspection as the only representative of China's bee industry. With the core value of "green, harmony and common growth", Laoshan pharmaceutical industry is striving to become the leader of the global bee industry while consolidating the leading position of the domestic bee industry.

本文链接: https://brand.waitui.com/2c2e6fd1c.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

2连板国脉科技:公司现已完成部分居家养老场景AI智能体的原型开发 相关技术成果尚未形成商业化收入

36氪获悉,国脉科技(002093.SZ)发布股票交易异常波动公告称,公司关注到部分媒体将公司列为AI智能体(AI Agent)核心龙头股。公司基于在身联网、智慧康养领域的技术积累,现已完成部分居家养老场景AI智能体(AI Agent)的原型开发,目前产品正处于场景适配度优化和用户体验提升阶段,相关技术成果尚未形成商业化收入,短期不会对公司经营业绩产生重大影响。敬请广大投资者关注技术转化周期风险,理性判断投资价值。

2小时前

我国近半地区提前实现2025年宫颈癌筛查目标

《中国疾病预防控制中心周报》近日公布了2023至2024年我国女性宫颈癌筛查率数据,35至64岁女性的整体筛查率超过50%。2023年,国家卫健委等10部门发布《加速消除宫颈癌行动计划(2023—2030年)》,设定了“到2025年我国适龄妇女宫颈癌筛查覆盖率达到50%、到2030年达到70%”的目标。2023至2024年,中国疾控中心团队在31个省份开展了宫颈癌筛查率调查。结果显示,35至64岁女性的筛查率达到51.5%,20岁及以上女性的筛查率为36.8%。35至64岁女性的整体筛查率已提前实现2025年目标。同时,我国接近一半的地区已提前实现2025年目标。农村筛查覆盖率为48.2%,仍低于2025年目标。(财联社)

2小时前

中创新航:公司股份获纳入港股通证券名单

36氪获悉,中创新航在港交所公告,根据上交所发布的通知,公司股份已获纳入沪港通下的港股通标的证券名单,并于2025年3月10日起生效。公司董事会认为,公司股份获纳入港股通标的证券名单,将有助于扩大本公司的投资群体,提升公司股票的流动性和市场活跃度。

2小时前

汤姆猫:公司在AI业务上确立了“AI+IP+Agent”的业务发展方向

36氪获悉,汤姆猫(300459.SZ)发布投资者关系活动记录表公告称,公司在AI业务上确立了“AI+IP+Agent”的业务发展方向,围绕该业务发展方向,公司将从以下几个维度深入推进产品的研发与升级工作:在产品形象上,汤姆猫家族IP包含6个经典的IP角色形象,公司将尽快推出不同IP形象的AI情感陪伴机器人,以满足不同用户对不同IP形象的喜爱需求。基于在多模态技术架构、大模型驱动、任务规划逻辑等方面的深层次共性,公司将在生态协作、情感化任务执行等领域探索与其他AI Agent的结合,将大模型、数据、工具多维一体融合进公司的家庭智能硬件终端上,推动AI从单一功能向“全能伙伴”演进。公司也将与各类机器人相关产业方探讨更丰富的产品形态,例如便于携带的小型机器人、能够运动的机器人等,持续丰富产品形态矩阵,满足用户在不同场景下的使用需求。

2小时前

长春一东:一汽股权公司拟减持不超3%公司股份

36氪获悉,长春一东公告,一汽股权投资(天津)有限公司计划通过集中竞价交易和大宗交易方式减持公司股份合计不超过424.55万股,即不超过公司总股本的3%。

2小时前

本页详细列出关于蜂之语的品牌信息,含品牌所属公司介绍,蜂之语所处行业的品牌地位及优势。
咨询